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Abstract. Recently, technologies such as DNA microarrays allow to
generate big scale of transcriptomic data used to the aim of exploring
background of genes. The analysis and the interpretation of such data
requires important databases and eﬃcient mining methods, in order to
extract specific biological functions belonging to a group of genes of an
expression profile. To this aim, we propose here a new approach for min-
ing transcriptomic data combining domain knowledge and classification
methods. Firstly, we propose the definition of Fuzzy Diﬀerential Gene
Expression Profiles (FG-DEP) based on fuzzy classification and a diﬀer-
ential definition between the considered biological situations. Secondly,
we will use our previously defined eﬃcient semantic similarity measure
(called IntelliGO), that is applied on Gene Ontology (GO) annotation
terms, for computing semantic and functional similarities between genes
of resulting FG-DEP and well known genetic markers involved in the de-
velopment of cancers. After that, the similarity matrices will be used to
introduce a novel Functional Spectral Representation (FSR) calculated
through a semantic ranking of genes regarding their similarities with the
tumoral markers. The FSR representation should help expert to inter-
pret by a new way transcriptomic data and infer new genes having similar
biological functions regarding well known diseases.
Availability: The semantic similarity measure and the ranking method
are available at http://plateforme-mbi.loria.fr/intelligo/ranking.
php.
1 Introduction
Nowadays, the pharmaceutical industries require large volume of biological data
and need a sophisticated computational methods to manage and extract relevant
knowledge. Recently, DNA microarrays were used for measuring the expression
levels of thousands of genes under various biological conditions. Hence, gene
expression data analysis proceeds in two steps: Firstly, expression profiles are
produced by grouping genes displaying similar expression levels under biological
situations [1]. Secondly, a functional analysis, based on functional annotations,
is applied on genes sharing the same expression profile, in order to identify their
relevant biological functions [2]. In fact, the main goal of this functional analysis
is to identify and characterize genes that can serve as diagnostic signatures or
prognostic markers for diﬀerent stages of a disease. One of the interesting source
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of functional annotations in the biological domain is the Gene Ontology (GO)
[3]. The interpretation of transcriptomic data requires eﬃcient mining methods
for extracting specific biological functions belonging to genes of an expression
profile. In this context, we introduce here, by an innovative way, a cascade of
methods for mining such data combining domain knowledge and classification
methods. Firstly, we propose the definition of Fuzzy Diﬀerential Gene Expression
Profiles (FD-GEP) based on fuzzy classification and a diﬀerential definition of
the expression between the considered biological situations. This classification
approach aﬀects genes through fuzzy sets when there are diﬀerential physiological
relations between the studied biological situations. Secondly, we will use our
previously defined eﬃcient semantic similarity measure (called IntelliGO), that
is applied on Gene Ontology (GO) annotation terms, for computing semantic and
functional similarities between genes of resulting FD-GEP and set of well known
genetic markers involved in the development of cancers. After that, the similarity
matrices will be used to introduce a novel Functional Spectral Representation
(FSR) calculated through a semantic ranking of genes regarding their similarities
with the tumoral markers. This new paradigm for visualizing expression data
displays as a bar code, genes of a given FD-GEP w.r.t. disease markers. Genes
that are at the top of the sorted list are functionally similar to these markers
and can hence be explored by biologists to verify experimental hypothesis.
This paper is organized as follows. The next section, outlines the presenta-
tion of the used dataset and introduce the new proposed method for profiles
extraction. The next subsections present the new gene functional analysis based
IntelliGO similarity and semantic Ranking. Finally, we discuss in the last section
the relevance of the obtained results of the proposed methods.
2 Material and Methods
2.1 DNA Microarrays Dataset
In this work, we will use a list (L) of 222 diﬀerentially expressed genes of col-
orectal cancers. An Aﬀymetrix HGU133+1 microarray was used for experiments.
In this dataset, we dispose of three biological situations in the gene expression
matrix (M) that correspond to three biological samples: (i) healthy tissue (nor-
mal); (ii): tumor tissue (cancer); (iii) cell line. We name these situations: S1, S2,
S3 respectively. Each situation represents the average of multiple replicates and
multiple specimens in each type of tissue during experiences [4]. An example of
the expression data in the matrix M is illustrated in Table 1. The expression
value for a given gene g from a set of genes G in a situation Si is given by νsi.
The selected 222 genes represent a significant fold change observed between S2
and S1. Thus biologists are interested by genes for which the expression varies
between these two situations, i.e., found deregulated in cancer tissues.
1 www.affymetrix.com/products_services/arrays/specific/hgu133plus.affx
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Table 1. Example of the expression matrix M of the 222 genes relative to colorectal
cancer, used in this study. This matrix is used for extracting gene expression profiles.
Gene Healthy : S1 Cancer: S2 Cell line: S3
KIAA1199 33,6 827,87 735,75
FOXQ1 65,36 1240,21 2631,71
PSAT1 89,03 1019,0 3025,66
CLDN1 12,15 119,9 78,5
SLC6A6 56,6 551,1 568,6
.... ... ... ...
Gene g νs1 νs2 νs3
.... ... ... ...
PSAT1 113,1 407,1 1258,0
2.2 Definition of the Fuzzy Diﬀerential Genes Expression Profiles:
FD-GEP
In the state-of-the-art methods for extracting expression profiles [1], there is no
prior exploitable knowledge between the nature of biological situations. How-
ever, the interpretation of groups of genes in an expression profile is usually
guided by hypothesizes related to the objectives of the study. This is the case
in particular when relations exist between the biological situations. Such kind
of relations could be temporal when expression levels are measured at diﬀerent
time stamp, or kinetic when a kind of a tissue is considered but in diﬀerent phys-
iological states (e.g. stages of tumor). In this last case, the diﬀerences existing
between pairs of situations may interest biologists, and it would be interesting to
regroup together genes with the same variations between two situations regard-
less of the level of expression they have each in one situation. This observation
conducts us to introduce here the notion of a priori definition of Diﬀerential
Genes Expression Profiles (D-GEP). It is the first contribution of this paper.
Constructed from pairs of situations chosen by the user, these profiles can be
considered as combinations, for each pair of situations, of theDiﬀerential Expres-
sion Sets (DES), to regroup genes having similar variations (over-expression, or
even under-expression) between two situations. The membership of a gene to
a given profile begins by studying its membership to a particular DES for each
pair of situations. Here we use a fuzzy modeling of the expression level variations
between two situations to consider noise in the data and provide an opportunity
for a gene to belong to more than one profile. With our data set, and having three
situations, we have 3 possible pairs of situations (S3, S1) (S2,S1) and (S3,S2),
respectively. For n situations, we can have n(n− 1)/2 pairs of situations. Identi-
fying a D-GEP for a gene g leads us to aﬀect this gene, for each pair of situation
(Si, Sj), either in the set of genes over-expressed in Si with respect to Sj (which
we denote Overi,j), or in the set of genes under-expressed in Si compared to Sj
(which we denote Under i,j), or rather in set of genes with similar expression in
Si w.r.t. Sj (which we denote Isoi,j). By extension, the sets Overi,j, Underi,j ,
Isoi,j are called Diﬀerential Expression Sets (DES), and allow to represent the
diﬀerential expression of genes between two situations of interest Si and Sj .
Consequently, the formal definition of a D-GEP is a K-uplet of DES, where K is
the number of pairs of situations. For example, in our case, the profile (Over3,1,
Over2,1, Under3,2), is a D-GEP in which genes are: over expressed in Cell Line
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(S3) w.r.t. Normal tissue (S1), over expressed in cancer (S2) w.r.t. Normal tis-
sue (S1), and under expressed in the Cell Line (S3) w.r.t. Cancer (S2). As we
said before, the aﬀectation of genes in the diﬀerent DES is performed with fuzzy
logic. Firstly, we need to define a value of variation of expression noted ξi,j to
represent the diﬀerence of the expression of a gene g in two situations (Si, Sj):
ξi,j(g) =
νsi−νsj
mink=1..n νsk
for all i, j in k situations. The proposed fuzzy model con-
ducts to define a threshold value σ for the expression variation value ξi,j(g), and
for each pair of situations (Si,Sj). Three membership functions of three fuzzy
sets allow to define the aﬀectation of genes to DES depending on the value of
ξi,j(g). These membership functions are defined as:
Overi,j : G −→ [0, 1] Overi,j(g) =


1 if ξi,j(g) ≥ σ
1
σ
× ξi,j(g) if 0 < ξi,j(g) < σ
0 otherwise
Underi,j : G −→ [0, 1] Underi,j(g) =


1 if ξi,j(g) ≤ −σ
−1
σ
× ξi,j(g) if −σ < ξi,j(g) < 0
0 otherwise
Isoi,j : G −→ [0, 1] Isoi,j(g) =


0 if ξi,j(g) < −σ or ξi,j(g) > σ
1
σ
× ξi,j(g) + 1 if − σ < ξi,j(g) < 0
−1
σ
× ξi,j(g) + 1 if 0 < ξi,j(g) < σ
The defuzzification process allows the final classification of a gene g to one
or more DES in accordance to a given threshold value µ. This is done with
the following constraint: if the value taken by function Overi,j(g), Underi,j(g)
or Isoi,j(g) is ≥ µ, thus the gene is classified in the corresponding DES. The
figure (1) represents the three membership functions Overi,j , Underi,j , Isoi,j .
For example, for the gene g, we have Overi,j(g) = 0.25, Underi,j(g) = 0,
Isoi,j(g) = 0.75. We observe that for µ = 0.5, this gene is classified in the
DES Isoi,j only, otherwise for µ = 0.25 it will be aﬀected both in Isoi,j with
membership probability of 0.75 and Overi,j with a complementary membership
value of 0.25. We can remark that with this modelization, the bi-classification
criteria of a gene in two DES is possible for µ ≤ 0.5. Hence, a D-GEP is a com-
bination of DES, and the fuzzy modelization introduced here allows to genes
to be aﬀected to more than one D-GEP. By consequence a Fuzzy diﬀerential
genes expression profile (FD-GEP) is a D-GEP where the aﬀectation of genes
in DES is performed with fuzzy logic. Note that, with 3 situations, and with
3 DES, we can obtain 27 possible FD-GEP. As we can observe, there are two
parameters that can be taken into account during the classification algorithm,
namely: σ and µ. The diﬀerent values aﬀected to these variables depend on the
used datasets. We performed an exploratory analysis by testing diﬀerent values
for µ={0.1, 0.2, 0.3, 0.4, 0.5} and σ={0.1, 0.2, 0.3, 0.4, 0.5, 0.6, 0.7, 0.8, 0.9,
1}. Each pair of values of the two parameters were tested for extracting the
possible FD-GEP profiles. Results for the diﬀerent combination are not shown
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Fig. 1. Representation of the membership functions defining the aﬀectation of a gene to
the diﬀerential expression sets Overi,j , Underi,j , Isoi,j used for defining the FD-GEP
profiles.
here. Although, we used some prior knowledge to eliminate certain values that
generate outliers FD-GEP profiles. For example, for σ ≥ 0.6 we observed that
some genes were classified in the DES Iso2,1 (same expression in cancer and nor-
mal tissues), even if in our dataset the genes are diﬀerentially expressed between
the two situations (S2) and (S1). We decided after multiple testing, to keep the
combination (µ,σ)=(0.3, 0.4) which expects a reasonable number of genes in the
obtained profiles. With this pair of values, and from the list of 222 colorectal
cancer genes, we extracted the FD-GEP expression profiles presented in Table
2. The number of genes in each profile is displayed in the diagonal of the matrix,
while overlaps (due to fuzzy classification) are observed between some profiles in
terms of number of shared genes are displayed in the rest of cells of the matrix.
Table 2. Distribution of genes in the obtained expression profiles. Note that if a cell
is empty then the two corresponding FD-GEP profiles do not share any gene. The
diagonal represents the number of genes in each FD-GEP.
Name of the FD-GEP Definition of the FD-GEP P
ro
fi
le
1
P
ro
fi
le
2
P
ro
fi
le
3
P
ro
fi
le
4
P
ro
fi
le
1
1
P
ro
fi
le
1
3
P
ro
fi
le
1
4
P
ro
fi
le
1
5
P
ro
fi
le
2
0
P
ro
fi
le
2
1
Profile 1 Over2,1 ,Over3,1,Over3,2 51 2
Profile 2 Over2,1 ,Over3,1,Under3,2 108 17 24 1
Profile 3 Over2,1 ,Over3,1,Iso3,2 30 1 1
Profile 4 Over2,1 ,Under3,1,Over3,2 1
Profile 11 Under2,1,Over3,1,Under3,2 1
Profile 13 Under2,1,Under3,1,Over3,2 9 1
Profile 14 Under2,1,Under3,1,Under3,2 7 1
Profile 15 Under2,1,Under3,1,Iso3,2 5
Profile 20 Iso2,1,Over3,1,Under3,2 56
Profile 21 Iso2,1,Over3,1,Iso3,2 1
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2.3 Gene Expression Functional Analysis
Calculating Semantic and Functional Similarity between Genes: A
lot of functional analysis methods have been proposed using either statistical
enrichment [5] or gene functional clustering [6]. In this last case, a semantic
similarity is used for grouping genes regarding Gene Ontology (GO) functions [3].
We admit that the performance of the used similarity will have an impact on the
clustering results. Recently, we proposed an hybrid functional analysis method
combining both fuzzy clustering and statistical enrichment analysis [7,8,9], using
our IntelliGO measure [10]. Our second contribution in this paper (after having
defined FD-GEP), is to propose a complementary visualization method that
should help biologists to investigate interesting genes during the transcriptomic
data study. The principle of the technique is detailed below.
In the rest of the experiments, we will use the same list of 222 colorectal can-
cer genes, for computing the IntelliGO similarity matrices. As a first step, and in
order to have a global overview of the distribution of the biological annotations
of the used list of genes, we produced a Heatmap with a two way hierarchical
clustering. The results are shown in figure (2). Despite the change in color in-
tensity in diﬀerent regions of the heatmap, several clusters can be distinguished
in its diagonal. Homogeneous cluster in the upper left of the heatmap and with
very little cross similarity with other genes in the data set has been studied
from the point of view of its gene content. The strong functional similarity be-
tween these genes can be explained by recurrent Biological Process annotations
on transport processes. Transport processes are important in the physiology of
the digestive system and cluster genes are already known to be deregulated in
colorectal cancer. This is the case of gene AQP8 aquaporin 8 whose expression
is no longer detectable in colorectal tumors [11]. In fact AQP8 gene is found
in the FD-GEP Profile 14 corresponding to genes under-expressed in tumor vs
the normal situation. Another gene (ATP11A) is also present in the functional
cluster analyzed here, with an annotation transport of phospholipids, and was
recently described as a new predictive marker of metachronous metastasis of
colorectal cancer [12]. Associated in our study to FD-GEP Profile 1, it actually
appears as over-expressed in tumor position relative to the healthy situation.
These two genes can be considered as positive controls, confirming the validity
of classification results.
Functional Spectral Representation: A Genes Functional Ranking Ap-
proach: As reported above, to enhance the analysis of the transcriptomic data,
we propose a new functional spectral representation of genes. The main idea of
the proposition is summarized in the Figure (3). Firstly, we proceed by ranking
with descending order (from most to less similar) an input list of genes regarding
their IntelliGO functional semantic similarity with given well known biological
markers. After the ranking step, we identify for a given FD-GEP profile, the
position of its genes in the ranked list. The position of each gene of this profile is
marked with a red line. Blue line indicates the 0.5 functional similarity thresh-
old. The main objective here is to verify if the genes belonging to the profile
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Fig. 2. Generated Heatmap with 222 colorectal cancer
(marked with red lines) are top ranked in the list or not, i.e., the number of red
lines over the blue line is important or not. If it is the first case, these genes
are judged to be functionally similar to the well-known biological markers and
therefore they could be suggested to biologists for further analysis.
In preliminary experiences, we have selected 6 genes involved in target WNT
signaling pathway2 known as transcriptionally repressed in colorectal cancer [13].
Genes of this pathway are known as contributors in mutations in degenerative
diseases and cancers. Namely we have chosen: AXIN2 (The Axin-related pro-
tein), CD44 (Cell-surface glycoprotein), MET (MNNG HOS Transforming gene),
MYC (v-myc myelocytomatosis viral oncogene homolog), SOX9 (SRY (sex de-
termining region Y)-box 9) and ASCL2.
Results for FD-GEP profile1 are presented in Figure (4). We can observe that
with AXIN2, MET, MYC, SOX9 markers, the blue line (50% of similarity) is
positioned in low levels of the ranked list. It means that genes of this profile are
very functionally similars to these markers, in particular with MET and MYC
(≥60% of genes of the profile) as it is shown in figure 5. We recall that these two
biomedical markers are confirmed to be catalyst in the colorectal cancer, and
we know that the studied data set is relative to this kind of cancer [14]. Thus,
these results confirm the pertinence of the proposed approach. For deepening
the analysis, we processed the same analysis for FD-GEP 2, 3, 14, 20 since
genes in these profiles are dysregulated in the cancer situation vs normal (either
Over or Under in S2 vs S1). We calculated for each profile its FSR and also the
average percentage of its genes having functional similarity w.r.t. the used cancer
biomedical markers over than 0.50. Results are shown in figure 5. We can observe
that all FD-GEPs except Profile 14 have similar functional background regarding
the used markers, and it appears very clearly that genes of the used data set
share biological processes that are very similar to MET and MYC cancer genes
(more than 40 %). Hence, we can suggest to biologists the top positioned genes
in the produced ranked lists of the FSRs of each profile, in order to verify their
2 http://www.genome.jp/kegg/pathway/hsa/hsa04310.html
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Fig. 3. A Functional Spectral Representation (FSR) overview illustrating the method.
A: An expression data matrix is used as input. B: The IntelliGO functional similarity
is calculated within all genes of the input list and a given bio-marker. C: The ranked
list is displayed by highlighting with red lines genes of a studied expression profiles. A
blue line is used to identify the 0.5 functional similarity threshold.
sequence similarity with the used markers. It could be then possible to extend
the WNT signaling pathway with those genes, and verify other hypothesis of
their involvement in the colorectal cancers.
3 Conclusion and Perspectives
In this paper, we proposed data mining methods combining classification and
visualization for analyzing transcriptomic data by an innovative way. In a first
step, we propose a new definition of the Fuzzy Diﬀerential Genes Expression Pro-
files FD-GEP, for classifying genes through fuzzy sets when there are diﬀerential
physiological relations between biological situations. After the step of profiles
extraction, a gene functional analysis is essential to give sense to the aﬀected
genes in the profiles. We propose a new functional analysis approach, with a new
paradigm for visualizing expression data through a process of semantic ranking
regarding interesting disease markers. Indeed, the proposed FSR displays as a
bar code, genes of a given FD-GEP w.r.t. disease markers. Genes that are at the
top of the sorted list are functionally similar to these markers and can hence be
explored by biologists to verify experimental hypothesis.
Further, we would consider the idea of performing the same study on
genes belonging to other disease processes. Indeed, the OMIM database (Online
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Fig. 4. Functional Spectral Representation (FRS) using genes of FD-GEP Profile 1
Fig. 5. Average percentage of genes of an FD-GEP having functional similarity w.r.t. a
cancer biomedical markers over than 0.50. Values are varying from a marker to another
for the considered FD-GEPs. We can observe that majority of the FD-GEP have similar
biological behavior regarding their functional similarities with biological functions of
the markers.
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Mendelian Inheritance in Man)3 provides markers for diﬀerent types of diseases
that are listed in this database. One can test these markers with diﬀerent lists
of gene expression data.
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